Hepatorenal syndrome

Common Name(s)

Hepatorenal syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatorenal syndrome" returned 55 free, full-text research articles on human participants. First 3 results:

Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndrome.
 

Author(s): Chiara Elia, Elsa Solà Vergés, Ezequiel Rodríguez, Pere Ginès

Journal: J. Hepatol.. 2015 Feb;62(2):493-5.

 

Last Updated: 19 Jan 2015

Go To URL
Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters?
 

Author(s): Claire Francoz, François Durand

Journal: J. Hepatol.. 2014 May;60(5):907-9.

 

Last Updated: 21 Apr 2014

Go To URL
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
 

Author(s): Hae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choi

Journal: Clin Mol Hepatol. 2013 Dec;19(4):417-20.

 

Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still ...

Last Updated: 24 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatorenal syndrome" returned 28 free, full-text review articles on human participants. First 3 results:

Hepatorenal syndrome.
 

Author(s): Jan Lata

Journal: World J. Gastroenterol.. 2012 Sep;18(36):4978-84.

 

Hepatorenal syndrome (HRS) is defined as a functional renal failure in patients with liver disease with portal hypertension and it constitutes the climax of systemic circulatory changes associated with portal hypertension. This term refers to a precisely specified syndrome featuring ...

Last Updated: 10 Oct 2012

Go To URL
Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice.
 

Author(s): Paolo Angeli, Pere Gines

Journal: J. Hepatol.. 2012 Nov;57(5):1135-40.

 

Hepatorenal syndrome (HRS) is a severe complication of cirrhosis that is associated with poor survival. A rapid diagnosis of HRS and a prompt initiation of the treatment with terlipressin and albumin are mandatory because this leads to an improvement of prognosis. This review covers ...

Last Updated: 19 Oct 2012

Go To URL
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.
 

Author(s): Mitra K Nadim, John A Kellum, Andrew Davenport, Florence Wong, Connie Davis, Neesh Pannu, Ashita Tolwani, Rinaldo Bellomo, Yuri S Genyk,

Journal:

 

Renal dysfunction is a common complication in patients with end-stage cirrhosis. Since the original publication of the definition and diagnostic criteria for the hepatorenal syndrome (HRS), there have been major advances in our understanding of its pathogenesis. The prognosis of patients ...

Last Updated: 4 Jul 2012

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
 

Status: Recruiting

Condition Summary: Hepatorenal Syndrome

 

Last Updated: 7 May 2015

Go to URL
Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
 

Status: Recruiting

Condition Summary: Hepatorenal Syndrome

 

Last Updated: 12 Jul 2014

Go to URL
A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
 

Status: Recruiting

Condition Summary: Hepatorenal Syndrome Type I and Type II

 

Last Updated: 2 Jun 2014

Go to URL